semaglutide vs tirzepatide vs liraglutide GLP-1 Medications for Weight Loss:

No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred

Tirzepatide Research Dosing (SURPASS/SURMOUNT Trial Protocols): Week 1-4: 2.5mg subcutaneously once weekly Week 5-8: 5mg once weekly Week 9-12: 7.5mg once weekly (or continue to higher doses) Week 13-16: 10mg once weekly Week 17-20: 12.5mg once weekly Week 21 onwards: 15mg once weekly (maximum studied dose) Some protocols used 10mg or 12.5mg as maintenance doses depending on tolerability

The choice often comes down to: Cost considerations (especially for cash-pay patients) Side effect profiles (individual tolerance) Patient preference after discussing options Insurance coverage (whats actually accessible) Providers like TrimRx offer both options, allowing you and your healthcare provider to choose based on your specific situation rather than being limited by insurance restrictions

They may recommend adjusting your dose, temporarily pausing treatment, or switching to an alternative medication if the symptom is significantly affecting your quality of life

Supporting your microdose schedule with nutrition and lifestyle A microdose tirzepatide schedule does not exist in a vacuum

Escalation typically proceeds: 2.5mg weeks 1-4, 5mg weeks 5-8, 7.5mg weeks 9-12, with potential increases to 10mg, 12.5mg, or 15mg